![]() |
|
|||
|
CHICAGO (Reuters) - Medtronic Inc's controversial orthopedic product Infuse, a bioengineered bone-growth protein used in spine surgery, is linked to a greater risk of cancer than previously thought, a prominent researcher said on Thursday.
|
| Thread Tools | |
| Display Modes | |
|
|